Ignite Creation Date:
2025-12-24 @ 6:28 PM
Ignite Modification Date:
2026-02-03 @ 12:22 PM
Study NCT ID:
NCT06484868
Status:
RECRUITING
Last Update Posted:
2025-07-03
First Post:
2024-06-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
Sponsor:
Amryt Pharma
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
APL-22
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None